DDB2, a gene mutated in XPE patients, is involved in global genomic repair especially the repair of cyclobutane pyrimidine dimers (CPDs), and is regulated by p53 in human cells. We show that DDB2 is expressed in mouse tissues and demonstrate, using primary mouse epithelial cells, that mouse DDB2 is regulated by E2F transcription factors. Retinoblastoma (Rb), a tumor suppressor critical for the control of cell cycle progression, regulates E2F activity. Using Cre-Lox technology to delete Rb in primary mouse hepatocytes, we show that DDB2 gene expression increases, leading to elevated DDB2 protein levels. Furthermore, we show that endogenous E2F1 and E2F3 bind to DDB2 promoter and that treatment with E2F1-antisense or E2F1-small interfering RNA (siRNA) decreases DDB2 transcription, demonstrating that E2F1 is a transcriptional regulator for DDB2. This has consequences for global genomic repair: in Rb-null cells, where E2F activity is elevated, global DNA repair is increased and removal of CPDs is more efficient than in wild-type cells. Treatment with DDB2-siRNA decreases DDB2 expression and abolishes the repair phenotype of Rb-null cells. In summary, these results identify a new regulatory pathway for DDB2 by E2F, which does not require but is potentiated by p53, and demonstrate that DDB2 is involved in global repair in mouse epithelial cells.
Introduction
Nucleotide excision repair (NER) removes a wide variety of DNA lesions, in particular cyclobutane pyrimidine dimers (CPDs) and (6-4) photoproducts induced by ultraviolet light (UV). Two pathways have been identified: transcription-coupled repair (TCR), which preferentially repairs DNA damage within transcribed DNA and global genomic repair (GGR), which refers to repair in the overall genome. Mutation in various genes involved in either pathway produces xeroderma pigmentosum (XP), rare autosomal recessive diseases characterized by a high incidence of UVinduced cancers. Eight XP complementation groups have been defined and associated with mutation in specific proteins involved in NER (for general reviews on NER and XP diseases see Friedberg et al., 1995) .
Mutations in the DDB2 gene are associated with the xeroderma pigmentosum group E (XPE) complementation group, which is characterized by deficiency in GGR (Hwang et al., 1999) . DDB2 is a small protein that associates with DDB1 to form the UV-damaged DNA binding (UVDDB) complex. This complex is critical as its binding to CPDs creates a major distortion of the DNA helix leading to the recruitment of xeroderma pigmentosum group C (XPC) and subsequent repair of the damage. Mutation in DDB2 affects UVDDB activity and compromises GGR, especially the repair of the CPDs.
It has often been written that rodent cells do not express DDB2, have low or no UVDDB activity or are deficient in GGR. Although this has been clearly demonstrated for Chinese hamster ovary cells (Hwang et al., 1998 ) and a few mouse fibroblast cell lines (Ishizaki et al., 1994; Tan and Chu, 2002) , these data have frequently been inappropriately extrapolated to all 'rodent' cells. In particular, there is some evidence that this is not the case in certain mouse cells: for example, we have reported that the level of GGR, especially the repair of CPDs, was similar in primary mouse hepatocytes and human fibroblasts (Prost et al., 1998b) . Others have also detected UVDDB activity and DDB2 expression in some cell lines (Zolezzi and Linn, 2000; Tan and Chu, 2002) . The question of DDB2 expression and its role in NER in mouse tissues had never been formally assessed and therefore needed clarification to better understand and appropriately compare murine with human repair responses.
Human DDB2 expression has recently been shown to be positively regulated by p53, a transcription factor critical for cellular responses to DNA damage, including DNA repair. Indeed, p53-deficient cells have reduced GGR, especially the repair of the CPDs, similar to DDB2 deficient cells (Prost et al., 1998a, b; Adimoolam and Ford, 2003 and references within) . The demonstration that in human cells DDB2 expression is dependent on functional p53, in the presence or absence of DNA damage, provided an explanation for this phenotype. However, the picture remains unclear for mouse cells, in which Tan and Chu (2002) recently showed that, unlike in humans, mouse DDB2 was not regulated by p53 in mouse embryonic fibroblast and a murine liver cell line.
The present study describes a new regulatory pathway for DDB2 in mouse hepatocytes.
Results

DDB2 is expressed in mouse tissues
We quantified DDB2 gene expression using real-time polymerase chain reaction (PCR) and checked the level of protein in nuclear extracts from various mouse tissues (Figure 1 ). Both mRNA ( Figure 1a ) and protein (1b) could be detected in all tissues tested, at variable levels. Expression was the highest in the lung, spleen and kidney, whereas nuclear levels of protein were greater in the liver and lung. Interestingly, a second band of lower molecular weight was observed in the spleen (data not shown).
Retinoblastoma deficiency increases DDB2 expression in a p53-independent manner DDB2 gene expression was detected in primary hepatocytes regardless of genotype tested (Figure 2a , white bars). In p53 null cells, the level of DDB2 gene expression was similar to that of wild-type (wt) cells (P ¼ 0.1312) but was significantly increased in retinoblastoma (Rb) null cells (P ¼ 0.0010). Protein could be immunoprecipitated from cells of all genotypes (data not shown); however using Western blotting, the protein could be detected only in Rb null cells, and only from 72 h after adenovirus infection (Figure 2b ), at which time the level of DDB2 transcription is correspondingly at least twofold higher than other genotypes and time points tested (Figure 2a) .
In human cells, DDB2 has been shown to be regulated by p53 both at basal level and after DNA damage. We have reported that p53, which is stabilized and activated in hepatocytes conditionally deficient in Rb (Sheahan et al., 2004) , is maximum 72 h after plating. We therefore investigated whether the increased DDB2 expression in Rb null cells was due to the overexpression of p53. Interestingly, Rb loss in p53 null cells was still able to increase DDB2 expression, although to a less substantial level than in cells with functional p53 (Figure 2c ). This suggests that p53 is not strictly required for induction of DDB2 after the loss of Rb, but is necessary to achieve a maximum induction of DDB2 expression in undamaged cells (Figure 2c) .
In human cells, DDB2 has been shown to be activated after UV-induced DNA damage in a p53-dependent manner. After UV however, DDB2 expression levels remained unchanged, in wt, p53 null or Rb null hepatocytes (Figure 2a , compare white and black bars).
Taken together, these results show that in primary mouse hepatocytes, DDB2 expression is not upregulated after UV damage, in agreement with Tan and Chu (2002) , but that acute loss of Rb affects the basal level of DDB2, to some extent through p53.
Increased DDB2 expression affects global DNA repair Human DDB2 is involved in GGR, especially the repair of CPDs. We assessed global DNA repair by quantifying unscheduled DNA synthesis (UDS) in wt and Rb null cells in which DDB2 expression is increased (Figure 3 ). The cells were UV-irradiated (10 J/m 2 ) to induce DNA damage and cultured in the presence of tritiated thymidine. Repair synthesis was then quantified by counting the number of radioactive grains revealed on a photoemulsion (examples are shown in the photos of Figure 3A ). The grain index reflects the incorporation of tritiated thymidine and therefore DNA repair synthesis. In untreated cells, the level of incorporation is low in more than 99% of the cells, showing that no DNA synthesis is occurring. One percent or less cells are found in replicative DNA synthesis and have a grain index of 100. After UV-irradiation, the grain density increased, regardless of genotype, reflecting DNA repair synthesis ( Figure 3A-C) . The box plot representation of grain indexes shows that unscheduled DNA synthesis increases after Rb deletion ( Figure 3B , Po0.0001). In p53À/À cells, in which we have previously reported a lower level of UDS than in wt cells (Prost et al., 1998a, b) , an increase in UDS is also consistently observed after Rb deletion ( Figure 3C) ; however it did In order to confirm the role of DDB2 in the repair phenotype of Rb null hepatocytes, we treated cells with DDB2 small interfering RNA (siRNA). This treatment reduced significantly the level of DDB2 RNA in the cells, to the level of untreated wt cells ( Figure 3D ) and prevented the increases in UDS ( Figure 3A , compare photos (e) and (f); Figure 3E ) (Po0.0001 in both wt and RbÀ/À cells treated with siRNA).
The technique of UDS does not discriminate between the repair of (6-4) photoproducts and CPDs. In fact, as UDS quantifies the repair within the first 4 h after UV treatment and repair of the (6-4) photoproducts is described to be 5-10 times faster than the repair of the CPDs, in some systems UDS is likely to reflect mainly the repair of the (6-4) photoproducts. However, as CPDs are more abundant than (6-4) photoproducts (75 versus 25%) after UV treatment, and as in primary hepatocytes, removal of CPDs and (6-4) photoproducts appear to have closer kinetics of repair (40% of (6-4) E2F, DDB2 and nucleotide excision repair S Prost et al versus 30% of CPDs repaired 4 h after UV (Prost et al., 1998a, b) ), it is likely that the difference in UDS observed is mainly due to the removal of CPDs.
To refine the UDS result we then investigated the ability of wt and RbÀ/À cells to specifically repair CPDs. We labelled the CPDs by immunofluorescence using a specific CPD antibody (a gift from T Mori) at indicated times after UV irradiation ( Figure 3G ). The images were captured under identical conditions in cells treated in parallel as described in Materials and methods. All parameters were precisely set to be constant, allowing for quantification analysis. In wt cells, the labelling of CPDs decreases slowly with time ( Figure 3G and H) usually becoming detectable by eye around 50 h after UV. By contrast in RbÀ/À cells, the intensity of CPDs labelling diminishes visibly as early as 6 h after UV. This confirms that RbÀ/À cells are repairing CPDs faster than wt cells. Interestingly, complete removal of the CPDs was not achieved even in RbÀ/À cells, 96 h after UV (data not shown).
E2F, DDB2 and nucleotide excision repair S Prost et al
Treatment of Rb null cells with DDB2 siRNA for 24 h delayed the repair of the CPDs in RbÀ/À hepatocytes ( Figure 3G and H).
E2F activates transcription of DDB2 with consequences for global DNA repair As Rb deletion does not require functional p53 to affect DDB2 expression levels (Figure 2b) , we analysed the mouse DDB2 promoter region (Ensembl Gene ID ENSMUSG00000002109) and identified a putative E2F binding site (also mentioned in Nichols et al., 2003) located 143-136 nucleotides upstream of the translation initiation site. We have previously shown that E2F transcriptional activity is elevated in Rb null hepatocytes (Sheahan et al., 2004) . We therefore tested the hypothesis that in murine cells DDB2 expression is regulated by E2F.
As several studies have reported a role for E2F1 in DNA damage response (Stevens and La Thangue, 2004 and references therein) and as in hepatocytes, whether wt of Rb null, we found that E2F1 gene expression is about fourfold higher than either E2F2 or E2F3 (data not shown), we concentrated on the effect of E2F1 inhibition.
Using an antisense against E2F1, we reduced E2F activity, together with DDB2 gene transcription ( Figure  4a and b). This was accompanied by a reduction of unscheduled DNA synthesis (Figure 4c ) (Po0.000 for wt and P ¼ 0.001 for RbÀ/À cells), suggesting that E2F1 is responsible for DDB2 activation and increased DNA repair.
However, the decrease in E2F activity after treatment with E2F1 antisense was somewhat stronger than expected. Indeed, the majority of E2F target promoters are regulated by several E2Fs (Ishida et al., 2001; Attwooll et al., 2004 and references therein) , and E2F2 and E2F3, which are also regulated by Rb, should therefore contribute to this reporter activity. It was suspected that E2F1 antisense may also inhibit E2F2 and E2F3 activity, despite no decrease in the mRNA level ( Supplementary Figure) . We therefore repeated this experiment using a siRNA against E2F1. As previously shown with the antisense, the siRNA against E2F1 decreased efficiently E2F1, RNA level, but not E2F2 or E2F3 (Supplementary Figure) , and to a lesser extent DDB2 (Figure 5 ), suggesting that E2F1 may regulate DDB2 expression.
To confirm this, we then performed chromatin immunoprecipitation (ChIP) assay. Hepatocytes in culture were lysed and proteins bound to the DNA were crosslinked as described in Materials and methods. After appropriate shearing, the DNA-protein complex was immunoprecipitated with two different antibodies against E2F1. Both antibodies pulled down DNA fragments that were amplified with primers specific for the 210 bp sequence surrounding the putative E2F site (data not shown and Figure 6a) , showing that E2F1 does bind to this sequence in murine hepatocytes. Although some specificity has been described (Takahashi et al., 2000) the majority of E2F target promoters seem to be regulated by several E2Fs (Ishida et al., 2001; Attwooll et al., 2004 and references therein) . We therefore repeated the ChIP analysis for E2F2 and E2F, DDB2 and nucleotide excision repair S Prost et al E2F3 and found that E2F3 but not E2F2 was able to bind the DDB2 promoter. Interestingly, E2F3 binding was increased in Rb null cells (Figure 6b ). E2F3 expression is unchanged in Rb null cells (data not shown) but the transactivation ability of a particular E2F may be conferred by the binding to protein partners (Attwooll et al., 2004) and does not simply depend on its level of expression (Muller and Helin, 2000) . This may explain the higher binding of E2F3 in Rb null hepatocytes and also indicates that, in some circumstances E2F2 could contribute to DDB2 expression, even if no binding was observed here.
Discussion
DDB2 is expressed in mouse tissues and affects DNA repair
The present results establish that DDB2 is expressed in mouse tissues, including in the liver where the nuclear protein level is high. The differences between expression and quantity of protein observed in the liver and lung suggest that mouse DDB2 protein is likely to be regulated by both post-translational modifications and regulation of gene expression, as described in human cells (Nag et al., 2001) . DDB2 gene expression and protein were also detected in primary hepatocytes. With these primary cells, using siRNA technology we were able to demonstrate that mouse DDB2 does have a role in global genomic repair, and specifically in the repair of CPDs. Our experiments do not rule out the possibility of DDB2 also having an effect on the repair of (6-4) photoproducts. Indeed, although expression of human DDB2 has no effect on the repair of (6-4) photoproducts in hamster cells (in which DDB2 is not normally expressed), it does have an effect in human cells: the repair of (6-4) is mildly defective in XPE patients (Tang and Chu, 2002 ) and references therein), and low levels of UVDDB stimulate the excision of (6-4) photoproducts by twofold (Wakasugi et al., 2002) . We also show for the first time that loss of Rb upregulates DDB2 and GGR by means of increased E2F activity. We have shown that E2F1-antisense or siRNA decreased DDB2 expression and DNA repair. Moreover, we show that both E2F1 and E2F3 are able to bind the DDB2 promoter. The recent finding from Berton et al. (2005) showing that E2F1-deficient mice have impaired DNA repair supports our finding that E2F affects DNA repair by means of regulation of repair proteins including DDB2. Intriguingly both DDB2 and E2F1-3 are normally cell cycle regulated. In human cell lines in culture, through a combination of post-translational modification and increased gene expression (Nag et al., 2001) , DDB2 protein increases during G1/S and peaks in S phase. Similarly, we observed in wt mouse primary hepatocytes that DDB2 mRNA and protein levels were maximum in S phase (Figure 2a and data not shown). The basis of this cell cycle regulation has never been investigated, but our demonstration that E2F1 and E2F3 are able to bind to a consensus site situated in the 5 0 untranslated region of the gene and that a decrease in E2F1 mRNA levels by siRNA or antisense is associated with decreased DDB2 expression proves that E2F regulates the expression of mouse DDB2, at least in hepatocytes. This finding provides for the first time, a plausible mechanism for the cell cycle regulation of expression of DDB2 as upon Rb phosphorylation in G1/S, E2F activity also increases to peak in S phase (for reviews, see Dyson, 1998; Muller and Helin, 2000) . Whether E2F transcriptionally regulates DDB2 in other species remains to be confirmed, but the identification of an E2F site downstream of the initiation of transcription site in human DDB2 suggests that this may also be the case in human cells (Nichols et al., 2003) .
DDB2 is not activated by p53
We (Prost et al., 1998a, b) and many other groups (reviewed in Adimoolam and Ford, 2003) have shown that p53 is involved in NER in both human and mouse cells and that loss of p53 function affects GGR, but not TCR Hanawalt, 1995, 1997; Prost et al., 1998b; Zhu et al., 2000) . This effect is more specific to the removal of CPDs than another UV-induced damage (6-4 photoproducts). These characteristics are similar to those of XPE cells bearing mutation in the DDB2 gene.
Human DDB2 expression has been shown to be regulated by p53 at both basal level and after DNA damage (Hwang et al., 1999) when p53 binds to a consensus site in the 5 0 untranslated region of DDB2 gene and stimulates DDB2 transcription (Tan and Chu, 2002) .
In a recent paper Wang et al. (2004) demonstrated in human cells that DDB2 is a downstream effector of p53, which recognizes CPDs and can stimulate XPC recruitment and binding at the site of damage (Fitch et al., 2003a) . This provides a clear explanation for the defect in global repair in p53-deficient human cells: lack of ChIP assay for E2F1-3. Total: total lysate before immunoprecipitation; No-Ab, non-antibody control; E2F1, E2F2, E2F3 using anti-E2F1-3 antibodies -VE, negative PCR control. E2F1 and E2F3 antibodies immunoprecipitate a DNA fragment that is amplified with the primers specific for a putative binding site in DDB2 5 0 untranslated region at the expected size.
E2F, DDB2 and nucleotide excision repair S Prost et al DDB2 jeopardizes the recruitment of XPC to the site of DNA damage and thus repair (Wang et al., 2004) .
Basal level of expression of DDB2 was similar in wt and p53 null cells (Figure 2a) . Furthermore, DDB2 expression did not significantly increase after UV irradiation in primary mouse hepatocytes (Figure 2a ) despite stabilization and activation of p53 (Sheahan et al., 2004) . This suggests that murine p53 does not directly regulate DDB2 gene expression, unlike in human cells, and is supported by a recent study showing that murine p53 is unable to bind the sequence corresponding to the p53-binding site identified in humans (Tan and Chu, 2002) . Interestingly however, although Rb deletion resulted in increased DDB2 gene expression regardless of p53 genotype (Figure 2c) , the effect was maximum in the presence of functional p53. The precise mechanism for this potentiation of the effect by p53 is unknown, but physical interaction of p53 with E2F1 (O'Connor et al., 1995) or other transcription factors (Ragimov et al., 1993) could be involved.
DDB2 and transcription
E2F activity is critical for the G1/S transition and is therefore tightly regulated. It has previously been shown that DDB2 interacts with E2F1 and together with DDB1, stimulates E2F1-activated transcription (Hayes et al., 1998; Shiyanov et al., 1999 , also reviewed by Tang and Chu, 2002) . Our results support the hypothesis that in untransformed primary mouse epithelial cells, activation of DDB2 by E2F could be critical for the regulation of the G1/S transition. In undamaged cells, DDB2 is activated by E2F, and in turn cooperates with DDB1 and E2F1 to transcriptionally activate genes required for DNA replication and G1/S transition. However, after DNA damage, DDB2's main function as a transcription cofactor switches to global repair, and the pool of protein, whose expression is not further activated in primary mouse hepatocytes, is likely to relocate to the site of damage as shown by Fitch et al. (2003a, b) using DDB2 overexpression systems. This decrease in available DDB2 would reduce the number of UVDDB-E2F1 complexes so reducing E2F1 transcriptional activity and promoting cell cycle arrest, as observed when the paramyxovirus simian virus 5v protein sequesters DDB2 protein (Lin et al., 2000) .
In conclusion, we show here that all mouse tissues tested express DDB2. Using mouse primary hepatocytes of various genotypes together with siRNA and antisense technology, we show, in an authentic, non-immortalized system, that DDB2 is regulated by E2F but not p53, and is involved in DNA repair, especially the repair of the CPDs. As the cells are not immortalized or selected for a deficiency, as no overexpression system is used, and as the phenotype is observed rapidly after Rb deletion, it is thought to reflect an authentic regulation rather than an artefact of cell culture or adaptation. Therefore, although mouse and human cells share a requirement for DDB2 in normal NER, they differ in requirement for p53 to regulate this process, but we have identified a new downstream regulatory role for E2F in DDB2 function that is important to mouse and perhaps human cells.
Materials and methods
Hepatocyte isolation, culture and adenovirus infection
The mice used were produced by crossing p53À/À (Purdie et al., 1994) with Rb-floxed mice that are homozygous for the Rb-floxed allele (exon 19 of the Rb gene is flanked by LoxP sequences) (Vooijs et al., 2002) . Wt specimens were littermates of the genetically modified animals. Primary hepatocytes, from adult mice (male, 6-12 weeks old), were isolated by two-step retrograde perfusion as described previously (Sheahan et al., 2004) . RbÀ/À cells are obtained by deletion of the Rb-floxed alleles in vitro by infection with an adenovirus expressing Crerecombinase (as we previously described (Prost et al., 2001) ). Deletion of Rb is completed within 16-24 h after infection (Prost et al., 2001) . Upon Rb deletion, RbÀ/À hepatocytes exhibit a high level of p53 that is active for transcriptional activation (Sheahan et al., 2004) .
DNA repair
For DNA repair studies, cells were UV-irradiated using a spectro-linker XL-1500 (Spectronics Corporation, Westbury, NY 11590, USA) fitted with UV-C bulbs (254 nm).
Unscheduled DNA synthesis was quantified as published previously (Prost et al., 1998b) . Briefly, cells were cultured in the presence of tritiated thymidine for 3 h after 10 J/m 2 . After 1 h chase, the slides were fixed, stained and covered with an autoradiographic emulsion (LM-1 -Amersham plc, Little Chalfont, UK). Nuclear grain counting was performed using image analysis software (Kontron KS400 version 3.4 -Zeiss, Carl Zeiss Ltd., Welwyn Garden City, UK). At the time of the experiments, less than 1% of the hepatocytes are in S phase, and replicative DNA synthesis is easily detectable with a grain index above 80. Box plot representation allows all the data to be plotted; a cell undergoing replicative DNA synthesis appears as an outliner and does not affect the overall result.
DNA repair of CPDs was quantified by immunofluorescence immediately after or at various times after UV irradiation (10 J/m 2 ). Cells were treated with ice-cold detergent (0.5% Triton, 0.2 mg/ml ethylenediaminetetraacetic acid, 1% bovine serum albumin (BSA)) and fixed in acetone/methanol (1:1 v/v). Immunodetection of CPDs was performed as described previously (Nishiwaki et al., 2004) using TDM-2 antibody (Mori et al., 1991) 1/5000 (a kind gift of T Mori), and revealed by an Alexa 488 rabbit anti-mouse secondary antibody. Nuclear counterstain is TO-PRO-3. Images were taken using a Zeiss LSM5-10 inverted confocal microscope using multitracking. Comparisons were made between cells that were treated, fixed and stained and imaged on parallel on the same days. The conditions used for the confocal analysis are very precisely set to be consistent (the laser intensity, gain, pinhole settings and time for exposure are kept constant for the whole series of images). An argon/krypton laser was used to excite fluorescein isothiocyanate at 488 nm at 6.1 A. The confocal aperture pinhole was set digitally at 17 mm. The image was visualized with a Zeiss Plan-Neofluar 40 Â /1.3 DIC-oil immersion objective. The contrast/brightness setting was selected so that the image for bright cells would not exceed being saturated (o255 for pixel intensity). All of the settings were kept constant throughout the analysis to yield unbiased measurements for each set of comparisons. Focus was done on randomly selected fields while 'fast scanning' for green immunofluorescence (CPD). The adjacent field was then scanned for green and blue fluorescence using multitracking scanning with four lines average and a digital image was acquired at a resolution of 1024 Â 1024. The intensity of nuclear green fluorescence in each cell was quantified using Image-pro plus software. An average of 40 cells were quantified per condition.
Immunodetection of DDB2 protein For primary hepatocytes: Total cell proteins were separated on a 10% sodium dodecyl sulphate-polyacrylamide gel electrophoresis, transferred to nitrocellulose, probed with anti-DDB2N antibody (directed against the N-terminal part of the protein) 1:50 for 3 h at room temperature (Zymed Laboratories, Invitrogen Ltd., Paisley, UK, ZMD06 cat. no. 34-2400) and revealed by the appropriate horseradish peroxidase secondary antibody (1:2000) (Dako UK Ltd., Ely, UK) and enhanced chemiluminescence þ . To confirm loading, the blot was probed using an anti-actin antibody (AB8227, AbCam plc, Cambridge, UK).
For tissues: Nuclear extract was prepared from murine tissues as previously described (Nag et al., 2001) . Immunoprecipitation was performed from equal amounts of protein (400 mg) using TrueBlott (eBioscience) according to the manufacturer's instructions using an antibody directed against the C-terminal part of the protein (DDB2C, Zymed Laboratories ZMD10, cat. no. 33-2800). The samples were run on a gel, transferred and detected using the different anti-DDB2N antibody to the N-terminal part of the protein as described above, and the secondary antibody provided in the immunoprecipitation kit. Hence DDB2 protein was precipitated and immunodetected using independent antibodies to different parts of the protein.
ChIP for DDB2
The DDB2 mouse gene (Ensembl Gene ID ENSMUS-G00000002109) was analysed and a putative E2F binding site, also reported by others (Nichols et al., 2003) , was identified located 143-136 nucleotides upstream of the translation initiation site.
Protein/DNA crosslinking was performed 96 h after cell plating by treatment with 1% formaldehyde at 371C for 10 min. Cells were then lysed and DNA was sheared by sonication, resulting in mainly 500-750 bp long DNA pieces. Immunoprecipitation was carried out using two different antibodies against E2F1 (Biomeda CA, US, and NeoMarkers, CA, USA), E2F2 (Santa Cruz Biotechnology, Inc., Santa Cruz, CA, USA, SC633, clone C-20) or E2F3 (Santa Cruz Biotechnology, Inc., SC878, clone C-18) and protein-A agarose. Immunoprecipitated DNA was purified and subjected to PCR using primers that cover DDB2 regulatory element (5 0 -CAAGACAGAAAATACTGTG-3 0 and 5 0 -CGAAGCAAG GAGTGGAAAAG-3 0 ) where the putative site for E2F was identified. The expected PCR product is 210 bp long.
E2F activity
Hepatocytes in culture for 48 h were transfected using TFx-50 (Promega Biotech, Southampton, UK) reagent (ratio 1/5 w/w DNA/lipid) as described previously (Prost et al., 1998b) . To control for transfection efficiency, cells were transfected with a mixture of pCMVb, constitutively expressing Lac Z and pE2F-TA-Luc (Mercury pathway profiling system, Clontech Laboratories, Inc., Mountain View, CA, USA) (ratio 1/10). Twenty-four hours after transfection, cells were scraped, and luciferase and bGal activities were quantified using Luciferase and bGalactosidase Assay reagents according to the manufacturer (Promega).
Antisense treatment
Mouse-specific E2F1 antisense and control antisense were purchased from Biognostik, Germany (cat. no. 11855-0203) . A mixture of three E2F1-specific or three control antisenses (100 mM) was added into the culture medium (50 ml of the mix per 6 cm plates) from 10 h after isolation. Medium was changed and more antisense was added every 24 h.
SiRNA treatment siGENOME SMARTpool siRNA mouse E2F1 (cat. no.M-044993-01) and mouse DDB2 (M-044959-00) were purchased from Dharmacon (Lafayette, CO, USA). These siRNA products are pools of four SMARTselection designed siRNA duplexes targeting mouse E2F1 and DDB2 mRNA transcripts respectively. SiGLO cyclophilin B siRNA was used as a positive control of transfection efficiency. Hepatocytes were plated in a six-well plates and treated with an adenovirus expressing Cre-recombinase (CRE) or DL70 adenovirus. At indicated times, the culture medium was replaced by medium containing 100 nM siRNA and 0.8% of DharmaFECT 1.1 (T-2001-02) transfection reagents, leading to a transfection efficiency above 70%.
SiRNA was added 24-48 h before fixing for analysis or harvesting cells for real-time PCR experiments.
Quantitative real-time PCR Total RNA was harvested at indicated times after virus infection, using Qiagen RNeasy mini-column (cat.no.74104; QIAGEN Ltd., Crawley, UK). Total RNA was eluted from the column in nuclease-free water before being re-concentrated by ethanol precipitation. Normally about 1-3 mg total RNA was obtained from the cells in a single well of a six-well plate. A260/ A280 ratios were measured by spectrophotometer Biomate 3 and were between 1.8 and 2.0. The RNA quality was also examined on RNA 6000 Nano LabChIP by an Agilend Bioanalyzer (Agilent Technologies, Santa Clara, CA, USA). cDNA was synthesized using MMLV (Qiagen) reverse transcriptase and an oligo-dT primer. RNA templates were removed at the end of reaction by RNase H. The efficiency of the reverse transcription was examined by PCR using a pair of b-actin primers.
We used Applied Biosystems's Taqman assays products and the reactions were run on an ABI Prism 7900 Sequence Detection System (AME Bioscience Ltd., Sharnbrook, UK). The genes studied were Gapd (MM99999915_q1), E2F1 (MM00432939_m1) and DDB2 (MM00651374_m1).
Statistical analysis
Analyses were carried out with Minitab for Windows (version 13.0). For unscheduled DNA synthesis, the nuclear index was arcsin-transformed, and analysis of variance (ANOVA) was performed using a general linear model, with, when appropriate, comparison with control using Bonferroni test. For expression levels, differences between means were evaluated with ANOVA. Satisfactory homogeneity of variances was determined with Bartlett's test. Differences were taken to be significant if Po0.05.
